In August 1650, 15 women and one man were publicly executed on Newcastle's Town Moor, with their bodies then buried in ...

Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...

By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

Like semaglutide, the new drug known as ecnoglutide is glucagon-like peptide-1 receptor agonist. In simple terms, they both ...

To find out how FDA’s new draft guidance, Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...

Russian Kirov-class nuclear-powered cruiser Admiral Nakhimov commenced sea trials on 18 August 2025 following a lengthy ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona"), an oncology-focused life sciences company developing innovative therapies based on its uniquely biocompatible gold nanorod ...

EmVenio Clinical Research expands global trial access with brand consolidation and launches Patient Navigator™ to improve access for trial participants.

Sona Nanotech Inc ( ($TSE:SONA) ) has shared an announcement. Sona Nanotech Inc. has provided an update on its first-in-human clinical trial for ...

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...